2024

1. Association of Serum Malondialdehyde Levels with Lipid Profile and Liver Function in Patients with Inflammatory Bowel Disease

   Antioxidants, Vol. 13, Núm. 10

2. Combined use of QRISK3 and SCORE2 increases identification of ankylosing spondylitis patients at high cardiovascular risk: Results from the CARMA Project cohort after 7.5 years of follow-up

   Seminars in Arthritis and Rheumatism, Vol. 66

3. Early identification of golimumab-treated patients with higher likelihood of long-term retention

   Frontiers in Immunology, Vol. 15

4. Effectiveness Of Tocilizumab In Aortitis And Aneurysms Associated With Giant Cell Arteritis

   European Journal of Internal Medicine, Vol. 129, pp. 78-86

5. Effectiveness of janus kinase inhibitors in relapsing giant cell arteritis in real-world clinical practice and review of the literature

   Arthritis Research and Therapy, Vol. 26, Núm. 1

6. Impact of multimorbidity on the first ts/bDMARD effectiveness and retention rate after two years of follow-up in patients with rheumatoid arthritis from the BIOBADASER registry

   Arthritis Research and Therapy, Vol. 26, Núm. 1

7. Interleukin-6 serum levels are associated with disease features and cardiovascular risk in patients with systemic sclerosis

   Clinical and Experimental Rheumatology, Vol. 42, Núm. 8, pp. 1564-1570

8. Liver Fibrosis Index-4 Does Not Correlate to Liver Elastography in Patients with Inflammatory Bowel Disease

   Journal of Clinical Medicine, Vol. 13, Núm. 21

9. Malondialdehyde Serum Levels in a Full Characterized Series of 430 Rheumatoid Arthritis Patients

   Journal of Clinical Medicine, Vol. 13, Núm. 3

10. Mean Platelet Volume Is Related to Cumulative Disease Damage in Patients with Systemic Lupus Erythematosus

    Life, Vol. 14, Núm. 4

11. Metabolic Syndrome: A Predisposing Factor for Rheumatoid Arthritis

    Journal of Rheumatology

12. Red blood cell distribution width as a surrogate biomarker of damage and disease activity in patients with systemic lupus erythematosus

    Clinical and Experimental Rheumatology, Vol. 42, Núm. 9, pp. 1773-1780

13. Relationship between the complement system and serum lipid profile in patients with rheumatoid arthritis

    Frontiers in Immunology, Vol. 15

14. Relationship of Hematological Profiles with the Serum Complement System in Patients with Systemic Lupus Erythematosus

    Biomedicines, Vol. 12, Núm. 5

15. SLESIS-R: an improved score for prediction of serious infection in patients with systemic lupus erythematosus based on the RELESSER prospective cohort

    Lupus Science and Medicine, Vol. 11, Núm. 1

16. Sex-specific impact of inflammation on traditional cardiovascular risk factors and atherosclerosis in axial spondyloarthritis. A multicentre study of 913 patients

    RMD open, Vol. 10, Núm. 2

17. Subcutaneous vs intravenous abatacept in rheumatoid arthritis-interstitial lung disease. National multicentre study of 397 patients

    Seminars in Arthritis and Rheumatism, Vol. 68

18. The Relationship between the complement system and subclinical carotid atherosclerosis in patients with rheumatoid arthritis

    Arthritis Research and Therapy, Vol. 26, Núm. 1

19. The complement system is linked to insulin resistance in patients with systemic lupus erythematosus

    Clinical and experimental rheumatology, Vol. 42, Núm. 1, pp. 115-121

20. Understanding the Role of the Complement System in Insulin Resistance and Metabolic Syndrome in Patients With Rheumatoid Arthritis

    The Journal of rheumatology, Vol. 51, Núm. 11, pp. 1069-1076